Evidence map›Paper›PMID 31483112›Full record

ArticleCurrent protocols in cell biology2019

Western Blotting with Solutions containing Nanoliter Volumes of Antibody.

David A Cruz Walma, Joshua W Collins

Open access · greenAbstract read
In one paragraph

Article in Current protocols in cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Open veterinary journal · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David A Cruz WalmaCell Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland.
Joshua W CollinsCell Biology Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland.
National Institute of Dental and Craniofacial Research · US

Funding

Craniofacial Developmental DynamicsZIADE000525 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI YAMADA, KENNETH · 2009 to 2025
$14.5M
Intramural NIH HHS Z99 CL999999Intramural NIH HHS ZIA DE000525
6 · The paper itself

Abstract

Whether screening small mammal serum during antibody production or attempting to preserve a stock of precious antibody, this protocol's western blotting method using aliquots containing nanoliter volumes of antibody will benefit researchers. Time-tested western blotting workflows allowing separation and analysis of proteins are routinely utilized in clinical and laboratory settings. The necessity for relatively large quantities of antibody is a major limitation to this universal tool. This article provides a step-by-step protocol for detecting proteins of interest with solutions containing nanoliter volumes of antibody without altering the preceding gel electrophoresis and transfer methods. Important considerations, frequently encountered problems, and means of optimizing reproducibility are discussed. Complementary diagrams, images, and videos are provided. The protocol is demonstrated using 0.3 nanoliters of anti-serum to detect fibronectin in a human foreskin fibroblast cell line. Finally, two support protocols detailing methods of extracting proteins from cultured cells are reported. Published 2019. This article is a US Government work and is in the public domain in the USA.

Indexed as

AnimalsAntibodiesBlotting, WesternCell LineFibroblastsFibronectinsHumansMicrochemistryNanotechnologySolutionsAntibodiesFibronectinsSolutionsantibodymicromininanoprotein detectionscreeningsmall volumewestern blot

Identifiers

PMID31483112
PMCPMC6727981
OpenAlexW2944492025

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.